Status:
COMPLETED
SMART Program for Paroxysmal Atrial Fibrillation
Lead Sponsor:
Massachusetts General Hospital
Conditions:
Paroxysmal Atrial Fibrillation
Stress
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
This is a pilot study to test the effects of the SMART-3RP (Stress Management and Resiliency Training Relaxation Response Resiliency Program) on quality of life, mental health, arrhythmia burden, and ...
Detailed Description
Mind-body practices that elicit the relaxation response (RR) have been used worldwide to prevent and treat disease. The Stress Management and Resiliency Training - Relaxation Response Resiliency Progr...
Eligibility Criteria
Inclusion
- Diagnosed with documented recurrent symptomatic PAF.
- Currently on stable medical therapy for AF and willing to continue on the same treatment regimen while participating in the study.
- No current daily practice of yoga, meditation, guided imagery or other techniques that elicit the RR.
- Able to provide informed consent and to understand written and spoken English.
Exclusion
- Allergy to adhesives that prevents wearing the HRV monitor.
- Patients unable or unwilling to participate in an intervention delivered via video conferencing.
- End Stage renal failure or heart failure, severe unstable medical or psychiatric disease.
- Patients deemed unable to complete protocol due to cognitive or other reasons.
- Patients on psychoactive medications will have eligibility determined by the PI or MD co-investigator on a case-by-case basis, and will be admitted to the study if medication is deemed stable
Key Trial Info
Start Date :
February 23 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 4 2019
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT03450993
Start Date
February 23 2018
End Date
January 4 2019
Last Update
March 2 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114